New hope for kids with rare brain tumors: Once-Weekly pill tested in japan

NCT ID NCT07441707

Recruiting now Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

First seen Mar 20, 2026 · Last updated Jun 11, 2026 · Updated 14 times

Summary

This study tests a new drug called tovorafenib in Japanese children, teens, and young adults (ages 6 months to 25 years) with a specific type of brain tumor (low-grade glioma) that has come back or is growing. The drug is taken as a pill once a week. The main goals are to check the drug's safety and how the body processes it, and also to see if it can shrink the tumors. Participants will be in the study for up to about 4 years, including treatment and follow-up.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hyogo Prefectural Kobe Children's Hospital
RECRUITING

Kobe, Japan
Kanagawa Children's Medical Center
NOT_YET_RECRUITING

Kanagawa, Japan
Kyoto University Hospital
RECRUITING

Kyoto, Japan
National Cancer Center Hospital
RECRUITING

Tokyo, Japan
National Center for Child Health and Development
RECRUITING

Tokyo, Japan
Osaka City General Hospital
RECRUITING

Osaka, Japan

Conditions

Explore the condition pages connected to this study.

LOW GRADE GLIOMA LOW-GRADE GLIOMA